KRAS and pancreatic neoplasm: The observation that Kras mutations occur at much higher frequency than pancreatic cancer in humans is recapitulated in mouse studies, where—although every single pancreatic epithelial cell expresses mutant Kras from the early pancreas development—PanIN lesions occur sporadically and only several weeks after birth.